Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

The European and Developing Countries Clinical Trials Partnership, the UK Medical Research Council, the National Institute for Health and Care Research Oxford Biomedical Research Centre, the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, the US Agency for International Development, and the Wellcome Trust.

Authors

Institutions

Publication Details

Journal
The Lancet Infectious Diseases
Published
2024-12-10
DOI
https://doi.org/10.1016/s1473-3099(24)00752-7
Citations
32
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
17.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

Nouhoum Koné, Carolyn M. Nielsen, Anyirékun Fabrice Somé, Ababacar Diouf et al.
32 citations
The Lancet Infectious Diseases
Malaria Research and Control
17.37
article

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

Nouhoum Koné, Carolyn M. Nielsen, Anyirékun Fabrice Somé, Ababacar Diouf, Katherine Skinner, Dimitra Pipini, Carole A. Long, Seydou Nakanabo Diallo, Jee-Sun Cho, Alison M. Lawrie, Edouard Ouédraogo, Simon J. Draper, Angela M. Minassian, Seyi Soremekun, Sarah E. Silk, Hamtandi Magloire Natama, Umesh Shaligram, John Bradley, Florence Ouédraogo, Massa dit Achille Bonko, Hermann Sorgho, Toussaint Rouamba, Kazutoyo Miura, Ousmane Traoré, Jo Salkeld, Rachel Roberts, Halidou Tinto, Lloyd D. W. King, F. Konaté, K. Carine Sonia Daboné, Z. Michael John Compaoré, Miguel Kafando
article en
32 citations

Abstract

The European and Developing Countries Clinical Trials Partnership, the UK Medical Research Council, the National Institute for Health and Care Research Oxford Biomedical Research Centre, the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, the US Agency for International Development, and the Wellcome Trust.

The Lancet Infectious DiseasesVol. 25(5)
National Institutes of Health (US), Serum Institute of India (India) (IN), University of Oxford (GB), London School of Hygiene & Tropical Medicine (GB), National Institute of Allergy and Infectious Diseases (US), Oxford BioMedica (United Kingdom) (GB), Jenner Institute (GB), Institut de Recherche en Sciences de la Santé (BF)
United States Agency for International Development, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Wellcome Trust, National Institute for Health and Care Research, Medical Research Council, NIHR Oxford Biomedical Research Centre, National Institute of Allergy and Infectious Diseases, NHLBI Division of Intramural Research, European and Developing Countries Clinical Trials Partnership
Good health and well-being
Openalex Percentile: Top 0%
Malaria Research and Control
17.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.